NovaBay Pharmaceuticals, Inc. (NBY)

NovaBay Pharmaceuticals Market Cap

NovaBay Pharmaceuticals has a market cap or net worth of $38.66 million as of March 5, 2026. Its market cap has increased by 1,071.65% in one year.

• Market Cap: 38.66M
• Enterprise Value: 36.80M
• 1-Year Change: 1,071.65%
• Ranking: #4714
• Category: Nano-Cap
• Stock Price: $1.48

Market Cap Chart

Since October 26, 2007, NovaBay Pharmaceuticals's market cap has decreased from $76.50M to $38.66M, a decrease of -49.46%. That is a compound annual growth rate of -3.65%.

Market Cap History

Date	Market Cap	% Change
Mar 4, 2026	36.80M	-94.82%
Dec 31, 2025	710.70M	24,406.90%
Dec 31, 2024	2.90M	123.08%
Dec 29, 2023	1.30M	-63.89%
Dec 30, 2022	3.60M	-78.70%
Dec 31, 2021	16.90M	-41.92%
Dec 31, 2020	29.10M	62.57%
Dec 31, 2019	17.90M	35.61%
Dec 31, 2018	13.20M	-77.70%
Dec 29, 2017	59.20M	18.64%
Dec 30, 2016	49.90M	612.86%
Dec 31, 2015	7.00M	-78.46%
Dec 31, 2014	32.50M	-32.85%
Dec 31, 2013	48.40M	43.62%
Dec 31, 2012	33.70M	-11.32%
Dec 30, 2011	38.00M	-1.55%
Dec 31, 2010	38.60M	-19.42%
Dec 31, 2009	47.90M	118.72%
Dec 31, 2008	21.90M	-72.63%
Dec 31, 2007	80.00M	4.58%
Oct 26, 2007	76.50M	-

View and export this data all the way back to 2007. Sign Up Today.

Related Stocks

Company	Market Cap
Sensei Biotherapeutics	39.77M
Jasper Therapeutics	39.74M
Atara Biotherapeutics	38.86M
Actinium Pharmaceuticals	38.37M
PDS Biotechnology	38.30M
Lisata Therapeutics	38.02M
Tvardi Therapeutics	37.71M
Tevogen Bio Holdings	37.52M